Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.

Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

One trend that the biotech industry in Europe has witnessed of late is the move towards climate-focused innovation, according to Annick Verween, head of specialist biotech incubator Biotope by VIB.

As U.S. budget cuts and freezes push healthcare and biopharma research in the States towards uncertainty, could Europe be the destination that science talent flocks towards? That’s what the European ...